MedPath

Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes

Not Applicable
Recruiting
Conditions
Alcohol Use Disorder
Posttraumatic Stress Disorder
Registration Number
NCT05564663
Lead Sponsor
Michigan State University
Brief Summary

The purpose of this study is to learn whether a mobile health application (mHealth App) for posttraumatic stress disorder (PTSD) with brief support can help individuals who are in treatment for alcohol problems.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Aged ≥ 18 years old
  • Currently in addictions treatment
  • Meet criteria for a current Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) AUD diagnosis
  • A score of 33 or greater on the PTSD Checklist (PCL-5)
  • Own a smart phone or other type of Wi-Fi-enabled device with App capabilities
Exclusion Criteria
  • Injection drug use in the past year
  • Patients who are unable to speak and/or understand English
  • Patients who are currently engaged in specific therapy for PTSD (Prolonged Exposure Therapy, Cognitive Reprocessing Therapy, EMDR)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
PTSD Checklist for DSM-5 (PCL-5) ChangeBaseline, 1-, 3-, 6-, and 12-months

The PCL-5 is a 20-item, self-reported measure that assesses the 20 DSM-5 symptoms of PTSD. Each symptom is measured on a 0-4 scale, with higher values indicating greater severity. Total scale scores range from 0 to 80.

Timeline Followback (TLFB) for Alcohol ChangeBaseline, 1-, 3-, 6-, and 12-months

The TLFB assessment method will be used to assess alcohol use in the past 30-days.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pine Rest Christian Mental Health Services

🇺🇸

Grand Rapids, Michigan, United States

Pine Rest Christian Mental Health Services
🇺🇸Grand Rapids, Michigan, United States
LeAnn Smart
Contact
Talal Khan
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.